Decision Matrix: Selecting a CRM vendor in the pharmaceutical industry (Competitor Focus)

Decision Matrix: Selecting a CRM vendor in the pharmaceutical industry (Competitor Focus)
  • Report price : $ 3 395
  • Publication date : November 2007
  • Length : 29 pages

Get this Report Now !

Decision Matrix: Selecting a CRM vendor in the pharmaceutical industry (Competitor Focus)

Introduction

This report provides a comparative analysis of the leading CRM vendors in the pharmaceutical market in order to help companies select a CRM solution based on its technology strength, reputation amongst end users and ability to influence the market.

Scope

  • Identifies which technology vendors pharmaceutical companies should ‘shortlist’ when considering the purchase of a CRM solution.
  • Provides a comparative technology assessment of the CRM solutions offered by leading vendors in the pharmaceutical market, globally
  • Identifies which CRM solution providers have the most impact on the pharmaceutical market
  • Explores how end users perceive CRM vendors across eight categories such as product quality and service capabilities


  • Highlights

    By combining robust CRM technology with extensive market impact in the pharmaceutical sector, Oracle is positioned as the leader for CRM solutions in the life sciences;

    With its recent acquisition of Dendrite, Cegedim has increased its market impact and has positioned itself as an important leader in the pharmaceutical CRM market;

    By offering new technology platforms StayinFront and Salesforce.com have become important players in the pharmaceutical CRM landscape; and While still a newcomer, Verticals onDemand, boasts domain expertise and a competitive end-user interface.

    Reasons to Purchase

  • Understand the topography of the competitive landscape for CRM in the pharmaceutical industry
  • Identify the strengths and weaknesses of leading CRM vendors and their solutions
  • Obtain insight into how IT managers in Pharma perceive key vendors in the market for CRM
  • RELATED REPORTS

    Pipeline Insight: Substance Dependence - Part I: Nicotine

    Pipeline Insight: Substance Dependence - Part I: Nicotine

    • $ 7 600
    • November 2007
    • 91 pages

    IntroductionThe high prevalence of nicotine dependence, strong uptake of Pfizer’s Chantix (varenicline), and the launch of new innovative therapies will cause the nicotine dependence prescription drug market to grow to $4.6 billion across the seven major markets by 2016. Innovative therapies are s ...

    | Countries : USA, Japan, France, United Kingdom

    King Pharmaceuticals: PharmaVitae Profile

    King Pharmaceuticals: PharmaVitae Profile

    • $ 5 700
    • November 2007
    • 107 pages

    IntroductionThis analysis examines the historical and forecast performance for King in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interact ...

    | Countries : USA

    Licensing Strategies - Examining Today’s Pharmaceutical Licensing Trends

    Licensing Strategies - Examining Today’s Pharmaceutical Licensing Trends

    • $ 15 200
    • November 2007
    • 162 pages

    IntroductionWith Pharma struggling to maintain its pipelines and portfolios with products developed in-house, companies are increasingly turning to licensing. However, the search for late-stage developmental products is becoming tougher and more expensive, and companies are now looking towards licen ...

    | Countries : Japan

    Pipeline Insight: Orphan Diseases in CNS - Part I: Huntington's Disease

    Pipeline Insight: Orphan Diseases in CNS - Part I: Huntington's Disease

    • $ 7 600
    • November 2007
    • 94 pages

    IntroductionThe current Huntington’s disease market is comprised of off-label prescriptions of psychotropic drugs. In the near term, two pipeline drugs are set to enter the market, demonstrating the viability of this disease as a primary marketing indication. In the longer term, with a strong gene ...

    | Countries : USA, Japan

    Commercial and Pipeline Insight: Systemic antifungals

    Commercial and Pipeline Insight: Systemic antifungals

    • $ 15 200
    • November 2007
    • 393 pages

    IntroductionThe systemic antifungals market accounts for $3.1bn of the total $41bn anti-infectives market. A wave of new products coinciding with patent expiry of two widely used compounds will shake up the market for systemic infections, further polarizing between winners and losers. Key changes a ...

    | Countries : USA, Japan, Germany, Spain, France, Italy, United Kingdom

    The Evolving Broadcast Value Chain, 2006 - 2012 (Review Report)

    The Evolving Broadcast Value Chain, 2006 - 2012 (Review Report)

    • $ 3 395
    • October 2007
    • 72 pages

    IntroductionNew technologies are enabling broadcasters to provide consumers with an increasing array of content services and viewing experiences. As these developments occur, there is pressure to remain competitive by reducing OpEx and boosting efficiencies. This review report outlines the key oppo ...

    | Countries : USA

    Key Markets in Healthcare for Technology Companies (US Markets for EMR, Virtual Reality, Wireless Technologies, RFID, and Medical Device Component Outsourcing)

    Key Markets in Healthcare for Technology Companies (US Markets for EMR, Virtual Reality, Wireless Technologies, RFID, and Medical Device Component Outsourcing)

    • $ 8 995
    • January 2007

    There is over a 30 billion dollar market for technology companies who assist the healthcare industry meet its challenges. This report is a combination of 5 Kalorama Information Market research reports - over 1100 pages of material. This report details the 5 areas Kalorama thinks will be the most pro ...

    Industries : Medical Devices | Countries : USA

    The Growing ``Out of Pocket`` Healthcare Market (Spending on Surgeries, Pharmaceuticals and Other Healthcare Services)

    The Growing ``Out of Pocket`` Healthcare Market (Spending on Surgeries, Pharmaceuticals and Other Healthcare Services)

    • $ 3 250
    • January 2007

    While insurance is the most common form of payment for healthcare services, increasingly customers are paying for their own expenses. Pharmaceutical, device and diagnostic companies, should recognize that a part of their revenues are originating directly or indirectly from out of pocket expenditures ...

    Industries : Pharmaceutical | Countries : USA

    Retail Clinics, The Emerging Market for Convenience and In-Store Healthcare

    Retail Clinics, The Emerging Market for Convenience and In-Store Healthcare

    • $ 2 995
    • January 2007

    Retail clinics, also known as convenience clinics, represent a disruptive innovation into the U.S. health care market, which evolved from and is uniquely positioned to benefit from the health care system’s shortcomings. These clinics present a new opportunity for retail outlets to earn more revenu ...

    Industries : Pharmaceutical | Countries : USA

    Small Firearms and Ammunition Market in the US

    Small Firearms and Ammunition Market in the US

    • $ 3 000
    • January 2007

    SBI forecasts after an estimated 10% growth in 2007, growth will soften substantially in 2008 due a softer U.S. economy, which will lower demand from civilian and commercial customers. Slightly better stability in Iraq and Afghanistan should also lower demand from the various military customers. How ...

    Industries : Aerospace and Defense | Countries : USA, Afghanistan

    24/7 Customer Service

    Contact Clare now !

    reportlinker.com © Copyright 2009. All rights reserved

    ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.